{"disease":{"id":"high-grade-serous-ovarian-fallopian-tube-or-primary-peritoneal-cancer","name":"high grade serous ovarian fallopian tube or primary peritoneal cancer"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05128825","title":"A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":310,"lead_sponsor_name":"K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}